Trajan Group Holdings Past Earnings Performance
Past criteria checks 0/6
Trajan Group Holdings's earnings have been declining at an average annual rate of -26.8%, while the Life Sciences industry saw earnings growing at 19.6% annually. Revenues have been growing at an average rate of 31.7% per year.
Key information
-26.8%
Earnings growth rate
-46.0%
EPS growth rate
| Life Sciences Industry Growth | 19.7% |
| Revenue growth rate | 31.7% |
| Return on equity | -1.3% |
| Net Margin | -1.1% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Fewer Investors Than Expected Jumping On Trajan Group Holdings Limited (ASX:TRJ)
Mar 01
What Does Trajan Group Holdings Limited's (ASX:TRJ) Share Price Indicate?
Sep 24Little Excitement Around Trajan Group Holdings Limited's (ASX:TRJ) Revenues As Shares Take 26% Pounding
Sep 09Earnings Miss: Trajan Group Holdings Limited Missed EPS By 86% And Analysts Are Revising Their Forecasts
Aug 29Are Investors Undervaluing Trajan Group Holdings Limited (ASX:TRJ) By 28%?
Jun 05Some Investors May Be Willing To Look Past Trajan Group Holdings' (ASX:TRJ) Soft Earnings
Sep 02Calculating The Intrinsic Value Of Trajan Group Holdings Limited (ASX:TRJ)
Feb 23Revenue & Expenses BreakdownBeta
How Trajan Group Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 159 | -2 | 53 | 0 |
| 30 Sep 23 | 160 | 0 | 52 | 0 |
| 30 Jun 23 | 162 | 2 | 50 | 0 |
| 31 Mar 23 | 153 | 3 | 48 | 0 |
| 31 Dec 22 | 144 | 4 | 45 | 0 |
| 30 Sep 22 | 126 | 3 | 40 | 0 |
| 30 Jun 22 | 108 | 1 | 35 | 0 |
| 31 Mar 22 | 95 | 0 | 33 | 0 |
| 31 Dec 21 | 83 | -1 | 31 | 0 |
| 30 Sep 21 | 80 | 0 | 29 | 0 |
| 30 Jun 21 | 77 | 2 | 27 | 0 |
| 31 Mar 21 | 75 | 3 | 25 | 0 |
| 31 Dec 20 | 73 | 5 | 22 | 0 |
| 30 Sep 20 | 72 | 4 | 22 | 0 |
| 30 Jun 20 | 72 | 3 | 22 | 0 |
| 30 Jun 19 | 68 | 2 | 21 | 0 |
| 30 Jun 18 | 57 | 1 | 21 | 0 |
| 30 Jun 17 | 54 | 1 | 24 | 0 |
Quality Earnings: TRJ is currently unprofitable.
Growing Profit Margin: TRJ is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TRJ is unprofitable, and losses have increased over the past 5 years at a rate of 26.8% per year.
Accelerating Growth: Unable to compare TRJ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TRJ is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (0.5%).
Return on Equity
High ROE: TRJ has a negative Return on Equity (-1.34%), as it is currently unprofitable.